skin neoplasms skin malignancies skin cancer melanoma basal cell carcinoma naevi huidkanker melanoom basaalcelcarcinoom
Conditions
Interventions
In the interventrion group the dermatoscope will be used after normal clinical evaluation in order to diagnose and evaluate the lesion. In the controlgroup the evaluation of the skin lesion ends after
Sponsors
UMCG
Eligibility
Inclusion criteria
Inclusion criteria: Patients are eligible for the study if they are 18 years of age or older, if they have a suspected skinlesion and if they have given informed consent.
Exclusion criteria
Exclusion criteria: Patients will be excluded if they already had a treatment for a skin malignancy, if they have a serious disease or if they cannot be asked to participate in this research (to the opinion of the general practitioner).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the diagnostic accuracy of the dermatoscope as diagnostic test for the evaluation of skinlesions. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures are: 1. Sensitivity; 2. Specificity; 3. The number of excisions/biopsies; 4. The number of referrals to secondary care; 5. The costs of both diagnostical strategies will be examined. | — |
Contacts
Public ContactC.J.L. Koelink
Antonius Deusinglaan 1
Outcome results
None listed